Kytril and Ovarian cancer - a phase IV clinical study of FDA data

Summary:

Ovarian cancer is found among people who take Kytril, especially for people who are 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Kytril and have Ovarian cancer. It is created by eHealthMe based on reports of 10,393 people who have side effects when taking Kytril from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

10,393 people reported to have side effects when taking Kytril.
Among them, 52 people (0.5%) have Ovarian cancer.

What is Kytril?

Kytril has active ingredients of granisetron hydrochloride. eHealthMe is studying from 10,432 Kytril users for its effectiveness, alternative drugs and more.

What is Ovarian cancer?

Ovarian cancer (cancer of ovary) is found to be associated with 1,123 drugs and 696 conditions by eHealthMe.

Number of Kytril and Ovarian cancer reports submitted per year:

Time on Kytril when people have Ovarian cancer *:

Age of people who have Ovarian cancer when taking Kytril *:

Common drugs people take besides Kytril *:

Common side effects people have besides Ovarian cancer *:

Nausea And Vomiting: 31 people, 59.62%
Tumor: 30 people, 57.69%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 30 people, 57.69%
Bone Disorder: 29 people, 55.77%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 29 people, 55.77%
Oedema Peripheral (superficial swelling): 28 people, 53.85%
White Blood Cell Count Decreased: 27 people, 51.92%
Anaemia (lack of blood): 27 people, 51.92%
Nausea (feeling of having an urge to vomit): 27 people, 51.92%
Abdominal Pain: 27 people, 51.92%

Common conditions people have *:

Neoplasm Malignant (cancer tumour): 25 people, 48.08%
Breast Cancer: 25 people, 48.08%
Migraine (headache): 25 people, 48.08%
Breast Cancer Metastatic: 25 people, 48.08%
Discomfort: 25 people, 48.08%
Hot Flush (sudden feelings of heat): 25 people, 48.08%
Granulocyte Count Decreased: 24 people, 46.15%
Ovarian Cancer Recurrent (reoccurrence of ovary cancer): 9 people, 17.31%
Headache (pain in head): 5 people, 9.62%
Back Pain: 5 people, 9.62%

* Approximation only. Some reports may have incomplete information.

Do you take Kytril and have Ovarian cancer?

Check whether Ovarian cancer is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Ovarian cancer and when was it recovered:

Ovarian cancer in Kytril

Expand to all the drugs that have ingredients of granisetron hydrochloride:

Ovarian cancer and drugs with ingredients of granisetron hydrochloride (68 reports)

Alternative drugs to, pros and cons of Kytril:

Kytril (10,432 reports)

Common Kytril side effects:

Browse all side effects of Kytril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ovarian cancer treatments and more:

Ovarian cancer (54,401 reports)

COVID vaccines that are related to Ovarian cancer:

Common drugs associated with Ovarian cancer:

All the drugs that are associated with Ovarian cancer:

Ovarian cancer (1,123 drugs)

Common conditions associated with Ovarian cancer:

Indigestion: 1,759 reports
Gastroesophageal reflux disease: 1,082 reports
Rheumatoid arthritis: 633 reports
Multiple sclerosis: 618 reports
Hormone replacement therapy: 601 reports
Gastric ulcer: 339 reports

All the conditions that are associated with Ovarian cancer:

Ovarian cancer (696 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on granisetron hydrochloride (the active ingredients of Kytril) and Kytril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.